Effect of HCG-Triggered Ovulation on Pregnancy Outcomes in Intrauterine Insemination: An Analysis of 5,610 First IUI Natural Cycles With Donor Sperm in China

Front Endocrinol (Lausanne). 2020 Jul 7:11:423. doi: 10.3389/fendo.2020.00423. eCollection 2020.

Abstract

Objective: To evaluate the effect of human chorionic gonadotropin (hCG) trigger ovulation on pregnancy outcomes in natural IUI cycles with donor sperm. Methods: This retrospective cohort study included 5,610 first-natural IUI cycles with donor sperm in infertile couples during the period from January 2012 to December 2017. To control for other confounding factors, our analysis was restricted to normo-ovulatory women without tubal infertility. The main outcome measure was live birth rate; the secondary outcomes included rates of clinical pregnancy and miscarriage. Results: In the crude analysis, both the clinical pregnancy (27.40 vs. 22.73%; P = 0.001) and live birth rates (24.52 vs. 20.13%; P = 0.007) were significantly higher for the hCG group than for the spontaneous LH group. After adjustment for a number of confounding factors, the reproductive outcomes were still significantly worse for the spontaneous ovulatory group. Conclusions: Among women undergoing natural cycle IUI with donor sperm, hCG triggered ovulation for timing insemination offers beneficial impacts on both clinical pregnancy rates and live birth rates.

Keywords: IUI; LH; hCG; ovulation; pregnancy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Birth Rate
  • China
  • Chorionic Gonadotropin / pharmacology*
  • Female
  • Fertilization in Vitro / methods*
  • Follow-Up Studies
  • Humans
  • Infertility / therapy*
  • Insemination, Artificial / methods*
  • Male
  • Ovulation / drug effects*
  • Ovulation Induction
  • Pregnancy
  • Pregnancy Outcome
  • Pregnancy Rate
  • Reproductive Control Agents / pharmacology
  • Retrospective Studies
  • Sperm Injections, Intracytoplasmic / methods*
  • Spermatozoa / cytology
  • Spermatozoa / drug effects
  • Tissue Donors

Substances

  • Chorionic Gonadotropin
  • Reproductive Control Agents